NO20016093L - Kloning og ekspresjon av en ny 5-HT4-receptor - Google Patents

Kloning og ekspresjon av en ny 5-HT4-receptor

Info

Publication number
NO20016093L
NO20016093L NO20016093A NO20016093A NO20016093L NO 20016093 L NO20016093 L NO 20016093L NO 20016093 A NO20016093 A NO 20016093A NO 20016093 A NO20016093 A NO 20016093A NO 20016093 L NO20016093 L NO 20016093L
Authority
NO
Norway
Prior art keywords
cloning
receptor
expression
novel
Prior art date
Application number
NO20016093A
Other languages
English (en)
Norwegian (no)
Other versions
NO20016093D0 (no
Inventor
Eckhard Bender
Armelle Nathalie Franco Pindon
Irma Petronella Van Oers
Mirek Jurzak
Walter Herman Maria Lou Luyten
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of NO20016093D0 publication Critical patent/NO20016093D0/no
Publication of NO20016093L publication Critical patent/NO20016093L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70571—Receptors; Cell surface antigens; Cell surface determinants for neuromediators, e.g. serotonin receptor, dopamine receptor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Neurology (AREA)
  • Pulmonology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Dermatology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
NO20016093A 1999-06-14 2001-12-13 Kloning og ekspresjon av en ny 5-HT4-receptor NO20016093L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9913850.5A GB9913850D0 (en) 1999-06-14 1999-06-14 Cloning and expression of a novel receptor
PCT/EP2000/005592 WO2000077199A1 (fr) 1999-06-14 2000-06-14 Clonage et expression d'un nouveau recepteur 5-ht4

Publications (2)

Publication Number Publication Date
NO20016093D0 NO20016093D0 (no) 2001-12-13
NO20016093L true NO20016093L (no) 2002-01-28

Family

ID=10855345

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20016093A NO20016093L (no) 1999-06-14 2001-12-13 Kloning og ekspresjon av en ny 5-HT4-receptor

Country Status (12)

Country Link
US (1) US6998244B1 (fr)
EP (1) EP1190057A1 (fr)
JP (1) JP2003502040A (fr)
KR (1) KR100689871B1 (fr)
AU (1) AU778107B2 (fr)
CA (1) CA2376389A1 (fr)
GB (1) GB9913850D0 (fr)
IL (1) IL147051A0 (fr)
NO (1) NO20016093L (fr)
NZ (1) NZ515479A (fr)
WO (1) WO2000077199A1 (fr)
ZA (1) ZA200110273B (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9913850D0 (en) 1999-06-14 1999-08-11 Janssen Pharmaceutica Nv Cloning and expression of a novel receptor
AU2003250112A1 (en) * 2002-07-22 2004-02-09 Bayer Healthcare Ag Regulation of human serotonin receptor
FR2846559B1 (fr) * 2002-10-31 2007-06-15 Centre Nat Rech Scient Composition pharmaceutique pour la preparation d'un medicament destine a traiter et/ou a prevenir une pathologie liee a une conduite obsessionnelle
US20070128603A1 (en) * 2003-05-28 2007-06-07 Bayer Healthcare Ag Diagnostic and therapeutics for diseases associated with 5-hydroxytryptamine (serotonin) receptor 7 (5-ht7)
US8084842B2 (en) * 2008-03-25 2011-12-27 Macronix International Co., Ltd. Thermally stabilized electrode structure
CN103614382B (zh) * 2013-10-28 2016-04-13 浙江大学 菜青虫5-羟色胺受体基因Pr5-HT8及其应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5472866A (en) * 1992-12-24 1995-12-05 Synaptic Pharmaceutical Corporation DNA encoding 5-HT4A serotonin receptors
GB9913850D0 (en) 1999-06-14 1999-08-11 Janssen Pharmaceutica Nv Cloning and expression of a novel receptor

Also Published As

Publication number Publication date
AU6150700A (en) 2001-01-02
GB9913850D0 (en) 1999-08-11
IL147051A0 (en) 2002-08-14
JP2003502040A (ja) 2003-01-21
NZ515479A (en) 2003-11-28
WO2000077199A1 (fr) 2000-12-21
US6998244B1 (en) 2006-02-14
NO20016093D0 (no) 2001-12-13
KR100689871B1 (ko) 2007-03-09
EP1190057A1 (fr) 2002-03-27
AU778107B2 (en) 2004-11-18
ZA200110273B (en) 2003-05-28
CA2376389A1 (fr) 2000-12-21
KR20010113052A (ko) 2001-12-24

Similar Documents

Publication Publication Date Title
DK1233964T3 (da) Ny anvendelse og hidtil ukendte N-azabicycloamidderivater
DK1394150T3 (da) 4-phenylpyridinderivater og deres anvendelse som NK-1-receptorantagonister
NO20013393D0 (no) Brönnsementeringsfremgangsmåter og sammensetninger
ID30262A (id) Ligan reseptor melanokortin
NO994177L (no) Atropisomere av 3-aryl-4(3H)-kinazoloner og deres anvendelse som AMPA-reseptor-antagonister
NO20020023D0 (no) Utförelse og utpröving av brukerprogrammer
DE69835748D1 (de) Akustisches pyrometer
NO995852L (no) Ny form av S-omeprazol
NO981469D0 (no) Ditiolanderivater, deres fremstilling og deres terapeutiske effekt
PL353241A1 (pl) Mutanty enzymu transpozazy i sposób ich zastosowania
DK1157005T3 (da) 3-phenylpyridinderivater og anvendelsen deraf som NK-1-receptorantagonister
NO20001323D0 (no) Dipeptid-apoptose inhibitorer og deres anvendelse
ID24409A (id) Struktur suatu jembatan gitar
EP1015473A4 (fr) CLONAGE ET EXPRESSION DU RECEPTEUR DE betaAPP-C100 (C100-R)
NO20016093D0 (no) Kloning og ekspresjon av en ny 5-HT4-receptor
NO20016059D0 (no) Propagering av bölger gjennom materialer
DK1178981T3 (da) Substituerede 3-pyridyl-4-arylpyrroler og deres terapeutiske og profylaktiske anvendelser
ATE297084T1 (de) Synchronisierung von pcm und pseudozufallstaktgebern
NO984921D0 (no) Tienopyridinderivater og deres anvendelse
NO20012667L (no) Fremgangsmåte for aktivering av vann og anvendelse av aktivert vann av denne type
NO20003128D0 (no) Nye p-aminofenylderivater og deres anvendelse
NO20014845D0 (no) Anvendelse av arylalkanoylpyridaziner
DK0869952T3 (da) Derivater af 5-naphthalen-1-yl-1,3-dioxaner, fremstilling og terapeutisk anvendelse heraf
GB9718808D0 (en) Cloning and expression of 5-HT receptor
FI104278B1 (fi) Parvekkeen tuentarakenne

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application